ALBERT, UMBERTO
ALBERT, UMBERTO
NEUROSCIENZE "RITA LEVI MONTALCINI"
8-week, single blind, randomized controlled trial comparing risperidone versus olanzapine augmentation of serotonin reuptake inhibitors in the treatment-resistant obsessive-compulsive disorder
2008-01-01 Maina G.; Pessina E.; Albert U.; Bogetto F.
A review of current strategies for treatment resistant obsessive-compulsive disorder
2008-01-01 Maina G.; Albert U.; Salvi V.; Bogetto F.
A systematic review of evidence-based treatment strategies for obsessive- compulsive disorder resistant to first-line pharmacotherapy
2018-01-01 Albert U.; Marazziti D.; Di Salvo G.; Solia F.; Rosso G.; Maina G.
Admixture analysis of age at symptom onset and age at disorder onset in a large sample of patients with obsessive-compulsive disorder
2015-01-01 Albert U.; Manchia M.; Tortorella A.; Volpe U.; Rosso G.; Carpiniello B.; Maina G.
ADVERSE EVENTS OF ANTIPSYCHOTICS AND CYTOCHROME POLYMORPHISMS: A CASE SERIES ON 31 PATIENTS
2021-01-01 Maina G.; Bramante S.; Borsotti A.; Oliva F.; Rigardetto S.; Albert U.
Affective recurrences in bipolar disorder after switching from lithium to valproate or vice versa: A series of 57 cases
2017-01-01 Rosso, Gianluca; Solia, Francesca; Albert, Umberto; Maina, Giuseppe
Alleanza terapeutica e D.O.C.
2006-01-01 Maina G.; Pessina E.; Saracco P.; Albert U.; Bogetto F.
Alternative anti-obsessional agents
2004-01-01 Maina G.; Albert U.; Bogetto F.
An exploratory study on obsessive-compulsive disorder with and without a familial component: are there any phenomenological differences?
2002-01-01 ALBERT U; MAINA G; RAVIZZA L; F. BOGETTO
Ansia e disturbo bipolare: comorbilità o epifenomeno?
2013-01-01 Umberto Albert; Francesca Barbaro; Giuseppe Maina; Filippo Bogetto
Ansia, depressione e disturbi da uso di sostanze: comorbidità e trattamento
2007-01-01 U. Albert; V. D’Ambrosio; G. Maina; F. Bogetto
Anti-brain antibodies in adult patients with obsessive-compulsive disorder
2009-01-01 Maina G.; Albert U.; Bogetto F.; Borghese C.; Cat Berro A.; Mutani R.; Rossi F.; Vigliani MC
Anti-brain antibodies in adult patients with obsessive-compulsive disorder (OCD)
2008-01-01 Vigliani M.C.; Albert U.; Brunatto C.; Candiloro L.; Franchino F.; Cat Berro G.; MAina G.
Anticorpi anti-SNC in adulti con disturbo ossessivo-compulsivo
2007-01-01 U. Albert; M.C. Vigliani; C. Brunatto; L.S. Candiloro; G. Maina.
Antipsicotici nel disturbo ossessivo-compulsivo resistente: la mancata risposta ad un primo antipsicotico predice la non risposta ad un secondo antipsicotico?
2007-01-01 U. Albert; E. Pessina; G. Maina
Antipsicotici nel DOC resistente: una mancata risposta ad un primo antipsicotico predice la non riposta ad un secondo antipsicotico?
2008-01-01 Albert U.; Pessina E.; Maina G.
Antipsychotic augmentation for treatment resistant obsessive-compulsive disorder: what if antipsychotic is discontinued?
2003-01-01 MAINA G; ALBERT U; ZIERO S; F. BOGETTO
Antipsychotics in obsessive-compulsive disorder
2005-01-01 MAINA G; ALBERT U; PESSINA E; SALVI V; BOGETTO F
Antipsychotics in treatment-resistant Obsessive-Compulsive Disorder: which antipsychotic, which dose and how long antipsychotic addition should be maintained
2016-01-01 Umberto Albert, Gabriele Di Salvo, Francesca Solia, Giuseppe Maina
Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study
2009-01-01 Pessina E; Albert U; Bogetto F; Maina G.